Rigel Pharmaceuticals, Inc. - Common Stock (NQ:RIGL)

39.96 -5.75 (-12.58%)

Delayed Quote Updated: 12:05 PM EST, Nov 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Rigel Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Rigel Pharmaceuticals: Q2 Earnings Insights ↗

August 02, 2022

Rigel Pharmaceuticals (NASDAQ:RIGL) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:01 PM. Here's what investors need to know about the announcement.

Via Benzinga

Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study ↗

August 02, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Earnings Outlook For Rigel Pharmaceuticals ↗

August 01, 2022

Rigel Pharmaceuticals (NASDAQ:RIGL) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here's what investors need to know before the announcement. Analysts estimate that Rigel...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

June 27, 2022

Gainers

Via Benzinga

Earnings Scheduled For August 2, 2022 ↗

August 02, 2022

Companies Reporting Before The Bell • Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion.

Via Benzinga

This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday ↗

June 28, 2022

Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court overturning Roe V Wade.

Via Benzinga

Mosaic Tumbles Around 10%, Here's 71 Biggest Movers From Yesterday ↗

June 24, 2022

Gainers Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) shares jumped 263% to $2.73 on Thursday. Blue Hat Interactive terminated its previously proposed shelf takedown...

Via Benzinga

44 Stocks Moving In Thursday's Mid-Day Session: F-star Therapeutics, Revlon And More ↗

June 23, 2022

Gainers Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) rose 83.8% to $1.3824. Blue Hat Interactive terminated its previously proposed shelf takedown offering.

Via Benzinga

63 Biggest Movers From Yesterday ↗

June 17, 2022

Gainers Advent Technologies Holdings, Inc. (NYSE: ADN) shares surged 244% to close at $3.99 on Thursday after the company announced it received notification of euro 782.1 million of funding from the...

Via Benzinga

3 Stocks Under $1 Insiders Are Buying ↗

June 14, 2022

The Nasdaq Composite dropped by more than 500 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 9, 2022 ↗

June 09, 2022

Upgrades

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

June 09, 2022

Good morning! We're starting off another day of trading with an overview of the biggest pre-market stock movers for Thursday!

Via InvestorPlace

18 Stocks Moving in Thursday's Pre-Market Session ↗

June 09, 2022

Gainers View, Inc. (NASDAQ: VIEW) rose 18.5% to $2.05 in pre-market trading after declining 5% on Wednesday.

Via Benzinga

83 Biggest Movers From Yesterday ↗

June 09, 2022

Gainers Symbotic Inc. (NASDAQ: SYM) shares surged 120.6% to settle at $20.07 on Wednesday. Symbotic reported the completion of its business combination with SVF Investment Corp. to become a publicly...

Via Benzinga

Mid-Afternoon Market Update: Dow Tumbles 300 Points; HeartCore Enterprises Shares Spike Higher ↗

June 08, 2022

U.S. stocks traded lower toward the end of trading, with the Dow Jones dipping over 300 points on Wednesday.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 08, 2022

Via Benzinga

Mid-Day Market Update: Crude Oil Rises 1%; Rigel Pharmaceuticals Shares Slide ↗

June 08, 2022

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite adding around 50 points on Wednesday.

Via Benzinga

Why Rigel Pharmaceuticals Shares Are Falling Today ↗

June 08, 2022

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) shares are trading lower after the company announced data from the FORWARD Phase 3 clinical trial of Fostamatinib did not demonstrate statistical significance...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 8, 2022 ↗

June 08, 2022

Upgrades

Via Benzinga

50 Stocks Moving In Wednesday's Mid-Day Session ↗

June 08, 2022

Gainers HeartCore Enterprises, Inc. (NASDAQ: HTCR) shares gained 81% to $1.8503 after the company authorized a $3.5 million buyback.

Via Benzinga

Rigel Pharmaceuticals' Fostamatinib Flunks In Late-Stage Rare Blood Disorder Trial ↗

June 08, 2022

Rigel Pharmaceuticals Inc (NASDAQ: RIGL) shares are falling on disappointing data from the FORWARD Phase 3 trial of fostamatinib in patients with warm autoimmune hemolytic anemia (wAIHA).

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

June 07, 2022

Good morning! We're starting off another day of trading with a breakdown of the biggest pre-market stock movers for Tuesday!

Via InvestorPlace

Stocks That Hit 52-Week Lows On Wednesday ↗

June 01, 2022

On Wednesday, 73 stocks hit new 52-week lows.

Via Benzinga

Knight Therapeutics Secures Rights To Rigel's Fostamatinib In Latin America ↗

May 24, 2022

Knight Therapeutics Inc. (TSX: GUD) (OTC: KHTRF)

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

May 03, 2022

Gainers

Via Benzinga

Recap: Rigel Pharmaceuticals Q1 Earnings ↗

May 03, 2022

Rigel Pharmaceuticals (NASDAQ:RIGL) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:01 PM. Here's what investors need to know about the announcement.

Via Benzinga

The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs ↗

May 03, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

Preview: Rigel Pharmaceuticals's Earnings ↗

May 02, 2022

Rigel Pharmaceuticals (NASDAQ:RIGL) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that Rigel...

Via Benzinga

Earnings Scheduled For May 3, 2022 ↗

May 03, 2022

Companies Reporting Before The Bell • Kiniksa Pharmaceuticals (NASDAQ:KNSA) is projected to report earnings for its first quarter.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 23, 2022 ↗

March 23, 2022

Upgrades For E2open Parent Holdings Inc (NYSE:ETWO), Colliers Securities upgraded the previous rating of Neutral to Buy. At the moment, the stock has a 52-week-high of $14.58 and...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.